CeriBell (CBLL) Competitors $24.69 +1.58 (+6.84%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$24.69 0.00 (0.00%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends CBLL vs. WRBY, LIVN, ENOV, NVCR, TMDX, LMAT, TNDM, SLNO, CNMD, and CDREShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include Warby Parker (WRBY), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), TransMedics Group (TMDX), LeMaitre Vascular (LMAT), Tandem Diabetes Care (TNDM), Soleno Therapeutics (SLNO), CONMED (CNMD), and Cadre (CDRE). These companies are all part of the "medical equipment" industry. CeriBell vs. Warby Parker LivaNova Enovis NovoCure TransMedics Group LeMaitre Vascular Tandem Diabetes Care Soleno Therapeutics CONMED Cadre CeriBell (NASDAQ:CBLL) and Warby Parker (NYSE:WRBY) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability. Is CBLL or WRBY more profitable? CeriBell has a net margin of 0.00% compared to Warby Parker's net margin of -4.39%. CeriBell's return on equity of 0.00% beat Warby Parker's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A Warby Parker -4.39%-8.26%-4.37% Does the media favor CBLL or WRBY? In the previous week, Warby Parker had 4 more articles in the media than CeriBell. MarketBeat recorded 9 mentions for Warby Parker and 5 mentions for CeriBell. Warby Parker's average media sentiment score of 0.49 beat CeriBell's score of 0.21 indicating that Warby Parker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Warby Parker 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer CBLL or WRBY? Warby Parker received 32 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 42.11% of users gave Warby Parker an outperform vote. CompanyUnderperformOutperformCeriBellOutperform Votes8100.00% Underperform VotesNo VotesWarby ParkerOutperform Votes4042.11% Underperform Votes5557.89% Do institutionals and insiders believe in CBLL or WRBY? 93.2% of Warby Parker shares are held by institutional investors. 26.6% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend CBLL or WRBY? CeriBell presently has a consensus target price of $32.60, suggesting a potential upside of 32.04%. Warby Parker has a consensus target price of $21.92, suggesting a potential downside of 8.76%. Given CeriBell's stronger consensus rating and higher possible upside, analysts plainly believe CeriBell is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Warby Parker 1 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has preferable earnings and valuation, CBLL or WRBY? CeriBell has higher earnings, but lower revenue than Warby Parker. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBellN/AN/AN/AN/AN/AWarby Parker$669.77M3.65-$63.20M-$0.27-89.00 SummaryWarby Parker beats CeriBell on 7 of the 13 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$827.90M$3.41B$5.84B$9.14BDividend YieldN/A1.64%4.75%3.86%P/E RatioN/A16.9226.7919.19Price / SalesN/A73.24435.4570.88Price / CashN/A44.0938.0134.83Price / BookN/A3.857.644.62Net IncomeN/A$92.00M$3.19B$246.06M7 Day Performance15.16%4.50%-2.12%-2.63%1 Month Performance6.24%9.09%-0.45%-2.15%1 Year PerformanceN/A12.27%16.26%12.88% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBellN/A$24.69+6.8%$32.60+32.0%N/A$827.90MN/A0.00N/ANews CoverageHigh Trading VolumeWRBYWarby Parker2.5369 of 5 stars$25.70-2.7%$21.77-15.3%+69.9%$2.61B$669.77M-95.193,491Upcoming EarningsAnalyst ForecastLIVNLivaNova3.7044 of 5 stars$47.68+0.1%$69.17+45.1%-15.6%$2.59B$1.15B113.522,900Upcoming EarningsENOVEnovis3.4525 of 5 stars$43.89+0.4%$64.83+47.7%-33.0%$2.50B$1.71B-20.046,550Short Interest ↓Positive NewsNVCRNovoCure3.4767 of 5 stars$22.48+3.5%$32.67+45.3%+44.9%$2.43B$509.34M-16.061,453Upcoming EarningsNews CoverageTMDXTransMedics Group3.6176 of 5 stars$72.18+1.3%$122.70+70.0%-15.2%$2.42B$241.62M76.79210News CoverageGap UpLMATLeMaitre Vascular2.0323 of 5 stars$98.65+1.7%$94.63-4.1%+64.2%$2.22B$193.48M53.91490Positive NewsTNDMTandem Diabetes Care4.0733 of 5 stars$33.47+2.6%$53.81+60.8%+24.0%$2.20B$747.72M-17.342,400Upcoming EarningsPositive NewsSLNOSoleno Therapeutics4.5359 of 5 stars$49.17-4.2%$71.20+44.8%-5.1%$2.12BN/A-14.8130News CoverageCNMDCONMED4.6526 of 5 stars$63.05-2.1%$77.20+22.4%-25.0%$1.95B$1.31B14.874,000CDRECadre2.8965 of 5 stars$35.14-1.6%$39.67+12.9%-6.1%$1.43B$482.53M42.342,435 Related Companies and Tools Related Companies Warby Parker Alternatives LivaNova Alternatives Enovis Alternatives NovoCure Alternatives TransMedics Group Alternatives LeMaitre Vascular Alternatives Tandem Diabetes Care Alternatives Soleno Therapeutics Alternatives CONMED Alternatives Cadre Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CBLL) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.